Voyxact Injection
Product Images NDC 59148-400

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Voyxact (NDC 59148-400). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Otsuka America Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Voyxact 01)

This text provides data on the estimated percent changes with 95% confidence intervals for different values. It includes values ranging from 20% to -70%, with specific data points for two groups: IV OXYACT 400 mg (n=152) showing a -50% change, and Placebo (n=168) showing a 2% change.*

FDA Label Image

Figure 2 (Voyxact 02)

FDA Label Image

Image (Voyxact 03)

This text provides a comparison between a medical device before and after use, featuring components such as the plunger rod, finger flange, needle guard, viewing window, needle, and needle cap. This information can be useful for understanding the functionality and maintenance of the device.*

FDA Label Image

Figure A (Voyxact 04)

FDA Label Image

Image (Voyxact 05)

This text mentions a prefilled syringe inside a box along with alcohol cotton balls, swabs, or gauze. Additionally, it refers to adhesive bandages and a sharps disposal container. This suggests the presence of a medical kit or first aid supplies.*

FDA Label Image

Figure B (Voyxact 06)

FDA Label Image

Figure C (Voyxact 07)

FDA Label Image

Figure D (Voyxact 08)

This text seems to be a set of instructions or information regarding a medical procedure, specifically an injection that should be administered by a caregiver or oneself. The location for this injection is likely the upper part of the body, as indicated by "upper." The text may be part of a larger document providing guidance on self-care or medical treatment.*

FDA Label Image

Figure E (Voyxact 09)

FDA Label Image

Figure F (Voyxact 10)

FDA Label Image

Figure G (Voyxact 11)

FDA Label Image

Figure H (Voyxact 12)

FDA Label Image

Figure I (Voyxact 13)

FDA Label Image

Figure J (Voyxact 14)

FDA Label Image

Figure K (Voyxact 15)

FDA Label Image

Figure L (Voyxact 16)

FDA Label Image

Principal Display Panel (200 mg/mL Syringe Carton)

This text appears to be describing a medication called Voyxact, which contains sibeprenlimab-szsi. The medication is in the form of an injection with a dosage of 400 mg/2 mL or 200 mg/mL. It provides instructions to store the medication in a refrigerator between 35°F to 46°F. The text also mentions that it is for subcutaneous use only. Additionally, it reminds to keep the medication out of reach of children and not to freeze it. For more information or prescribing details, one can visit the website mentioned or scan the provided QR code.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.